Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05676008 · ClinicalTrials.gov registry record · NA

A Study of Positive Emotions With Long COVID-19

A NA study of Post-Acute COVID-19 Syndrome, sponsored by University of California, Davis.

Active
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT05676008 is a NA study of Post-Acute COVID-19 Syndrome that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 400 participants, below the 815-participant average among 14 other Post-Acute COVID-19 Syndrome trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05676008, a NA study of Post-Acute COVID-19 Syndrome, is active but no longer recruiting, sponsored by University of California, Davis.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

This study is testing a new brief mindfulness practice for people suffering from long COVID-19 symptoms. People suffering from long COVID are particularly vulnerable to negative emotions, as they must also cope with the long-term uncertainty of physical and psychological stress beyond the acute infection. The goal of the study is to measure the ability of a brief mindfulness practice to promote a sense of well-being in people suffering from long COVID.

Interventions

  • BEHAVIORAL Microdosing of mindfulness

Study Locations (1)

California

  • University of California Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2023-01-12
Est. Completion 2026-04
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT05676008

The ClinicalTrials.gov registry entry for NCT05676008 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 815-participant average among 14 other Post-Acute COVID-19 Syndrome trials with a reported enrollment target (51% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post-Acute COVID-19 Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Microdosing of mindfulness is the first listed.

NCT05676008 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05676008 about?

NCT05676008 is a clinical study titled "A Study of Positive Emotions With Long COVID-19". This study is testing a new brief mindfulness practice for people suffering from long COVID-19 symptoms. People suffering from long COVID are particularly vulnerable to negative emotions, as they must also cope with the long-term uncertainty of physical and psychological stress beyond the acute infe...

What is the current status of trial NCT05676008?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-01-12. Estimated completion is 2026-04.

What conditions does trial NCT05676008 study?

This clinical trial studies the following conditions: Post-Acute COVID-19 Syndrome.

What interventions are being tested in trial NCT05676008?

The interventions under investigation include: Microdosing of mindfulness (BEHAVIORAL).

Who is sponsoring clinical trial NCT05676008?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05676008 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post-Acute COVID-19 Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.